CD274 and cancer: It is further proved by KEGG pathway analysis which revealed that cancer-driving signaling and PD-L1 signaling in HARA-B are prominently impaired, as marked by the down-regulated DEGs in the top-ranked pathways (Fig. 7F, Fig. S12B, Table S4).